KCLI | EUPIC | |
---|---|---|
Price | $29.4 | € 3.69 |
Marketcap M | $282.24 | € 101.47 ($ 114.97) |
ROE % | 2.6 | 11.8 |
PE | 14.11 | 6.55 |
PTBV | 0.36 | 0.78 |
Div Yield % | 3.67 | 6.5 |
Tuesday, June 9, 2020
Update on My Insurance Holdings
Kansas City Life Insurance (OTC:KCLI) is a smallcap
life and health insurance company with a long and stable history.
In the company's Q1 earnings report their investments were down $38 M due to the market
downturn. Consequently
the company equity dropped $3 per share but
book value is still $81 per share.
KCLI makes 30% of its revenue from
investments, therefore investment income is critical to be profitable.
But in this low interest environment
the company must sacrifice safety to get decent yield.
The company
has more than half of its assets in corporate bonds. Virtually
all of its bonds are investment grade, but there is still a lot
at the bottom tier of investment grade.
When the downturn happened, there was a big fear that we would
see a wave of corporate downgrades and defaults.
Fortunately, the Fed pulled out the bazooka and said it was
willing to buy up corporate debt to shore up the market.
In the report, the company still has $779 M of equity, even
after factoring in Q1 losses.
That may seem like plenty but the company's capital and surplus (equity) for statutory regulation
purposes is only $260 M at 2019 year end. This $260 M amount is used by
regulators determine if the company is solvent and can do more business.
So a deep downturn in the bond market can be
very scary for the company. But they dodged a bullet, maybe, as the
bond market has been quite bullish recently.
KCLI is a really conservative old insurance company.
The Bixby family has run it for four generations! Philip Bixby CEO has run the company for
the last two decades. Because the company is so stable, past data can be very useful
to understand the company and its management intentions.
In the last 15 years,
their overall book value has gone from $692 M to $779 M.
Over the same period, their shares outstanding have gone from 11.9 M to 9.6 M, as
they have consistently tried to buy their shares back, mostly in the $40-$50 range.
So the net result is that
their book value per share has gone from $51 to $81 in 15 years.
That's a paltry 3.13% return.
Along with equity growth, shareholders also get a steady dividend.
Sadly, since the current CEO has taken over the company twenty years ago, they
have never increased the dividend, although one year, they did distribute
a special dividend of
$2 per share.
The stock is right now at $29.40 after the recent market drop, but at this level
it still
hasn't recovered like the favoured US large caps.
If the company could return to around $36, that is a 3% dividend.
Add the dividend to the 3.13% equity growth and
overall,
shareholders can expect around a 6.13% return.
This isn't a great return, but I just live with KCLI as a steady
source of income. If I have spare cash, I can put it to work at KCLI.
Or if I want to get adventurous, I could borrow money to buy KCLI. With interest
rates so low, I can pocket the spread between the dividend and the
interest cost.
My second insurance holding is European Reliance (ATH:EUPIC).
This company is similar to KCLI. It does life, health and auto insurance for the Greek
market.
EUPIC had a great 2019, the company earned € 17.5 M, and € 22.4 M pre-tax.
Of the pre-tax profit, € 7.3 M was from underwriting, and all other was € 15.1 M.
As expected however,
Q1 2020 was bad news. The company's book value dropped by € 13 M.
Again, it was better than I feared, because I saw that they have downside exposure to
€ 30 M of Greek mutual funds.
The ratios in the table are as of Q1 2020, so they still aren't bad.
If
that is the worst of it, EUPIC is a good company selling for really cheap.
And it is very generous with the dividends.
I added to my position during this downturn.
That's the second update of my holdings. Next post I will update my cigarette stocks.
Wednesday, June 3, 2020
Adding More Japanese Value Stocks
In the last entry I described my view that the way
to win in this market is to arbitrage across time and
markets.
I've described here that right now the US largecap market is the
most overpriced ever.
But many overseas markets are reasonable. I am quite heavily invested in
Japan and South Africa. I feel quite strongly the coming decade is
going to be all about emerging markets and value stocks.
Japan is a value country. It is a very developed
country that has been heavily discounted for a generation. But, whereas
in previous times Japanese companies mainly disregarded the minority
shareholders, now they are much more generous. One
can find dozens and dozens of companies that pay more than 3% dividends,
and are growing dividends around 10%.
Yes, the persistent explanation for stocks being so cheap is the aging population
and their ballooning debt. But look at the US. Their debt is getting
up there, and the dollar is stronger than ever.
And the same goes for the euro.
In March this year, the US market fell 35% off the peak.
And I took the opportunity to add to my Japanese holdings. The table here shows
the four stocks I currently own. The latter two I have had for
7 years. Both are up more than 3x when factoring in dividends.
I also added two new stocks. My main criteria
are
San | Takamatsu | Tachibana | Riken | |
---|---|---|---|---|
Price | ¥ 1234 | ¥617 | ¥ 1760 | ¥2402 |
Marketcap (M) | ¥ 13820.80 ($ 127.38) | ¥ 6663.60 ($ 61.42) | ¥ 45760.00 ($ 421.75) | ¥ 56687.20 ($ 522.46) |
ROE % | 6.8 | 9 | 6.3 | 8.7 |
PE | 7.45 | 4.71 | 10.42 | 13.78 |
PTBV | 0.51 | 0.42 | 0.66 | 1.27 |
Div Yield % | 2.59 | 4.05 | 2.73 | 1.67 |
P/NCAV | ‐ | 0.6 | 0.71 | ‐ |
- little or no debt
- high dividend yield
- growing dividends
- low PE
Subscribe to:
Posts (Atom)